What Researchers Did
Researchers conducted a randomized prospective study with 10 patients undergoing free tissue transfer, randomizing them to receive either hyperbaric oxygen therapy postoperatively for seven days or no therapy (control group).
What They Found
Among the 10 patients studied, no significant difference was observed between the two groups in terms of flap survival, resolution of venous congestion, or oedema. Specifically, hyperbaric oxygen therapy did not lead to better survival of free flaps or improved postoperative recovery compared to the control group.
What This Means for Canadian Patients
Canadian patients undergoing free flap surgery may not routinely benefit from hyperbaric oxygen therapy to improve flap survival or recovery. Current evidence suggests that this specific adjunctive treatment may not be necessary for better outcomes in microvascular tissue transfer.
Canadian Relevance
This study has no direct Canadian connection or specific relevance to Canadian healthcare policies or practices.
Study Limitations
A significant limitation of this study is its very small sample size of only 10 patients, which limits the generalizability of the findings.